Ashik Desai: Guilty Plea, Star Witness, 7-Month Sentence

Ashik Desai is the former Outcome Health executive who pleaded guilty to wire fraud in December 2019, cooperated with federal prosecutors as their star witness against the company’s three top executives, and was sentenced in September 2024 to seven months in federal prison. He joined the Chicago health-technology company as a teenage intern, rose to Executive Vice President by his early twenties, and admitted to running the day-to-day mechanics of a scheme that defrauded pharmaceutical clients, lenders, and investors of close to $1 billion.

From Intern to Executive Vice President

Desai started at the company, then called Context Media, in June 2012 as a 19-year-old Northwestern University student. Company co-founder and CEO Rishi Shah is a Northwestern alumnus.1Yahoo News. Former Outcome Health Exec Ashik Desai Sentenced to 7 Months After graduating in 2013, Desai was hired full-time and promoted quickly. By his early twenties he was Vice President of Business Growth and Analytics, supervising the sales team and a team of data analysts.2SEC. SEC Complaint, SEC v. Rishi Shah et al., 19-cv-07528 He eventually became Executive Vice President and part of the “inner circle” with Shah, co-founder and President Shradha Agarwal, and Chief Financial Officer Brad Purdy.

Desai had been accepted to medical school and deferred, then gave up the spot to stay at Outcome Health. At his peak he earned $500,000 a year.1Yahoo News. Former Outcome Health Exec Ashik Desai Sentenced to 7 Months

What Desai Did Inside the Fraud

Outcome Health sold advertising to pharmaceutical companies for tablets and screens placed in doctors’ offices. Between 2011 and 2017 the company sold ad space on devices it did not have, billed clients for campaigns that were only partly delivered or never ran, and used the inflated revenue to raise hundreds of millions from investors and lenders.3Department of Justice. Three Former Executives Sentenced for $1B Corporate Fraud Scheme The overbilling alone reached at least $45 million, and audited financials overstated revenue by at least 23 percent, with $14.3 million overstated in 2015 and $30 million in 2016.4SEC. SEC Litigation Release No. 24675

According to the SEC’s civil complaint and Desai’s later testimony, he ran several of the mechanics. Starting in late 2013 he supervised an internal process called “list matching,” in which sales contracts were padded with doctors’ offices and devices that were not actually in the company’s network. The SEC described it as “selling on futures” without telling clients the inventory did not exist.2SEC. SEC Complaint, SEC v. Rishi Shah et al., 19-cv-07528

When campaigns fell short, Desai signed affidavits certifying to pharmaceutical clients that the ads had run as contracted. The SEC alleged those certifications were false. He also oversaw internal “delta reports” tracking the gap between what had been promised and what had actually been delivered, a shortfall the company hid from clients.2SEC. SEC Complaint, SEC v. Rishi Shah et al., 19-cv-07528

Desai was also responsible for the return-on-investment studies the company gave to clients and prospective investors. A third-party analytics firm produced the studies, but when the results missed guaranteed performance thresholds, Desai personally altered the final calculations, changing prescription-lift figures, revenue projections, and statistical confidence levels.5SEC. SEC Amended Complaint, SEC v. Rishi Shah et al., 19-cv-07528 During the 2016–2017 capital raise he sat in on presentations to institutional investors, answered their questions, and presented the manipulated ROI results as genuine.2SEC. SEC Complaint, SEC v. Rishi Shah et al., 19-cv-07528

Guilty Plea and SEC Settlement

A Wall Street Journal investigation in October 2017 exposed the company’s practices. Desai was placed on leave soon after and formally resigned in April 2018.2SEC. SEC Complaint, SEC v. Rishi Shah et al., 19-cv-07528

On November 25, 2019, federal prosecutors in Chicago unsealed criminal charges against six former employees, including Desai, Shah, Agarwal, and Purdy. The SEC filed a parallel civil complaint the same day, alleging violations of the antifraud provisions of the Securities Act and the Securities Exchange Act.6Department of Justice. Former Executives and Employees of Outcome Health Charged4SEC. SEC Litigation Release No. 24675

In December 2019, Desai pleaded guilty to one count of wire fraud and agreed to cooperate with federal prosecutors. On February 4, 2020, he settled the SEC’s civil fraud allegations in Chicago federal court, with monetary relief and penalties left to be determined later.7Chicago Tribune. Former Outcome Health Executive Ashik Desai Settles SEC Fraud Allegations

Star Witness at the Founders’ Trial

Desai’s cooperation became the backbone of the government’s case against the founders. At the trial of Shah, Agarwal, and Purdy in early 2023, he took the stand and admitted his own role, testifying that he had been taught the “corrupt practices” as part of the company’s business model and that he had instructed his team to falsify information. “I was part of the business practices, and I led the team that was doing it, but it was not just me,” he told the jury.8Chicago Tribune. In Outcome Health Trial, Defense Tries to Prove Witness Was Responsible for Fraud

Defense attorneys argued the opposite: that Desai was the real architect of the scheme and had kept the founders in the dark. They pointed to his own admissions that he had lied to Shah about operating with integrity and had misled Purdy about fabricated ROI reports. They called his testimony self-serving and reminded jurors that his plea deal gave prosecutors the ability to recommend a reduced sentence for truthful cooperation.8Chicago Tribune. In Outcome Health Trial, Defense Tries to Prove Witness Was Responsible for Fraud

On April 11, 2023, after a ten-week trial, the jury convicted all three founders. Shah was found guilty on 19 counts including mail fraud, wire fraud, bank fraud, and money laundering. Agarwal was convicted on 15 counts. Purdy was convicted on 13.9Department of Justice. Former Executives of Outcome Health Convicted in $1B Corporate Fraud Scheme

Seven Months in Federal Prison

On September 19, 2024, U.S. District Judge Thomas Durkin sentenced Desai to seven months in federal prison for his wire fraud conviction. At sentencing, prosecutors noted that Desai was employed, that his employer knew about his criminal history and remained supportive, and that he had been meeting with interns at his workplace to discuss the consequences of what he had done. Desai told the court he intended to keep telling his story to business students and recent graduates as a cautionary tale about a “fake it until you make it” mentality.1Yahoo News. Former Outcome Health Exec Ashik Desai Sentenced to 7 Months

How Desai’s Sentence Compares

Desai’s seven-month sentence was well below what the founders received. Judge Durkin estimated that Outcome Health’s pharmaceutical clients suffered a $23.3 million loss from the fraud, though he ruled that investors did not suffer a loss relevant under the sentencing guidelines.10Courthouse News Service. Disgraced Chicago Tech Star Gets 7 1/2 Years in Jail The sentences handed down to the founders and two cooperating junior analysts were: